Jiang He

ORCID: 0000-0002-8286-9652
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Sodium Intake and Health
  • Hormonal Regulation and Hypertension
  • Nutritional Studies and Diet
  • Chronic Kidney Disease and Diabetes
  • Cardiovascular Health and Risk Factors
  • Dialysis and Renal Disease Management
  • Genetic Associations and Epidemiology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Acute Ischemic Stroke Management
  • Diet and metabolism studies
  • Birth, Development, and Health
  • Renin-Angiotensin System Studies
  • Cardiovascular Health and Disease Prevention
  • Obesity, Physical Activity, Diet
  • Heart Rate Variability and Autonomic Control
  • Nutrition, Genetics, and Disease
  • Liver Disease Diagnosis and Treatment
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Function and Risk Factors
  • Lipoproteins and Cardiovascular Health
  • Renal function and acid-base balance
  • Heart Failure Treatment and Management
  • Cardiovascular Disease and Adiposity
  • Epigenetics and DNA Methylation

Tulane University
2016-2025

Southwest University
2025

The University of Texas Southwestern Medical Center
2016-2025

Southwestern Medical Center
2025

The First Affiliated Hospital, Sun Yat-sen University
2018-2025

Sun Yat-sen University
2012-2025

Sinopec (China)
2025

National Institute of Diabetes and Digestive and Kidney Diseases
2004-2024

Soochow University
2014-2024

University of Maryland, Baltimore
2015-2024

Because of the rapid change in lifestyle China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate prevalence among Chinese adults.

10.1056/nejmoa0908292 article EN New England Journal of Medicine 2010-03-24

Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities hypertension prevalence, awareness, treatment, and control in 2010 compared secular changes from 2000 to 2010.We searched MEDLINE 1995 through 2014 supplemented with manual searches retrieved article references. included 135 population-based studies 968 419 adults 90 countries. Sex- age-specific prevalences each country were applied population data calculate regional numbers...

10.1161/circulationaha.115.018912 article EN Circulation 2016-08-08

IMPORTANCE Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide.OBJECTIVE To investigate prevalence diabetes glycemic control in Chinese adult population.DESIGN, SETTING, AND PARTICIPANTS Using a complex, multistage, probability sampling design, we conducted cross-sectional survey nationally representative sample 98 658 adults 2010.MAIN OUTCOMES MEASURES Plasma glucose hemoglobin A 1c levels were measured after at least 10-hour overnight...

10.1001/jama.2013.168118 article EN JAMA 2013-09-03
Bin Zhou Rodrigo M. Carrillo‐Larco Goodarz Danaei Leanne M Riley Christopher Paciorek and 95 more Gretchen A Stevens Edward W. Gregg James E. Bennett Bethlehem Solomon Rosie Singleton Marisa K. Sophiea Maria LC Iurilli Victor P. F. Lhoste Melanie Cowan Stefan Savin Mark Woodward Yulia Balanova Renata Cífková Albertino Damasceno Paul Elliott Farshad Farzadfar Jiang He Nayu Ikeda André Pascal Kengne Young‐Ho Khang Hyeon Chang Kim Avula Laxmaiah Hsien-Ho Lin Paula Margozzini Maira J. Jaime Miranda Hannelore Neuhauser Johan Sundström Cherian Varghese Indah Suci Widyahening Tomasz Zdrojewski Leandra Abarca-Gómez Ziad Abdeen Hanan F Abdul Rahim Niveen M E Abu-Rmeileh Benjamín Acosta-Cázares Robert J. Adams Wichai Aekplakorn Kaosar Afsana Shoaib Afzal Imelda Angeles‐Agdeppa Javad Aghazadeh-Attari Carlos A. Aguilar‐Salinas Charles Agyemang Noor Ani Ahmad Ali Ahmadi Naser Ahmadi Nastaran Ahmadi Fariba Ahmadizar Soheir H. Ahmed Wolfgang Ahrens Kamel Ajlouni Rajaa Al‐Raddadi Monira Alarouj Fadia AlBuhairan Shahla AlDhukair Mohamed M. Ali Abdullah Alkandari Ala’a Alkerwi Kristine H. Allin Eman Aly Deepak Amarapurkar Norbert Amougou Philippe Amouyel Lars Bo Andersen Sigmund A. Anderssen Ranjit Mohan Anjana Alireza Ansari-Moghaddam Daniel Ansong Hajer Aounallah-Skhiri Joana Araújo Inger Ariansen Tahir Aris Raphael E. Arku Nimmathota Arlappa Kavumpurathu Raman Thankappan Thor Aspelund Félix Assah Maria Cecília F Assunção Juha Auvinen Mária Avdićová Ana Azevedo Mohsen Azimi‐Nezhad Fereidoun Azizi Mehrdad Azmin Bontha V. Babu Suhad Bahijri Nagalla Balakrishna Mohamed Bamoshmoosh Maciej Banach Maja Banadinović Piotr Bandosz José R Banegas Joanna Baran Carlo M Barbagallo Alberto Barceló

Hypertension can be detected at the primary health-care level and low-cost treatments effectively control hypertension. We aimed to measure prevalence of hypertension progress in its detection, treatment, from 1990 2019 for 200 countries territories.

10.1016/s0140-6736(21)01330-1 article EN cc-by The Lancet 2021-08-24
Daniel Taliun Daniel Harris Michael D. Kessler Jedidiah Carlson Zachary A. Szpiech and 95 more Raúl Torres Sarah A. Gagliano Taliun André Corvelo Stephanie M. Gogarten Hyun Min Kang Achilleas Pitsillides Jonathon LeFaive Seung‐been Lee Xiaowen Tian Brian L. Browning Sayantan Das Anne‐Katrin Emde Wayne E. Clarke Douglas P. Loesch Amol C. Shetty Thomas W. Blackwell Albert V. Smith Quenna Wong Xiaoming Liu Matthew P. Conomos Dean Bobo François Aguet Christine M. Albert Álvaro Alonso Kristin Ardlie Dan E. Arking Stella Aslibekyan Paul L. Auer John Barnard R. Graham Barr Lucas Barwick Lewis C. Becker Rebecca Beer Emelia J. Benjamin Lawrence F. Bielak John Blangero Michael Boehnke Donald W. Bowden Jennifer A. Brody Esteban G. Burchard Brian E. Cade James F. Casella Brandon Chalazan Daniel I. Chasman Yii‐Der Ida Chen Michael H. Cho Seung Hoan Choi Mina K. Chung Clary B. Clish Adolfo Correa Joanne E. Curran Brian Custer Dawood Darbar Michelle Daya Mariza de Andrade Dawn L. DeMeo Susan K. Dutcher Patrick T. Ellinor Leslie Emery Celeste Eng Diane Fatkin Tasha E. Fingerlin Lukas Forer Myriam Fornage Nora Franceschini Christian Fuchsberger Stephanie M. Fullerton Søren Germer Mark T. Gladwin Daniel J. Gottlieb Xiuqing Guo Michael E. Hall Jiang He Nancy L. Heard‐Costa Susan R. Heckbert Marguerite R. Irvin Jill M. Johnsen Andrew D. Johnson Robert C. Kaplan Sharon L. R. Kardia Tanika N. Kelly Shannon Kelly Eimear E. Kenny Douglas P. Kiel Robert Klemmer Barbara A. Konkle Charles Kooperberg Anna Köttgen Leslie A. Lange Jessica Lasky‐Su Daniel Levy Xihong Lin Keng‐Han Lin Chunyu Liu Ruth J. F. Loos

Abstract The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic architecture and biology of heart, lung, blood sleep disorders, with ultimate goal improving diagnosis, treatment prevention these diseases. initial phases focused on whole-genome sequencing individuals rich phenotypic data diverse backgrounds. Here we describe TOPMed goals design as well available resources early insights obtained from sequence data. include a variant browser, genotype...

10.1038/s41586-021-03205-y article EN cc-by Nature 2021-02-10

Background: The metabolic syndrome is a common risk factor for cardiovascular disease. Objective: To examine the association between and chronic kidney disease microalbuminuria. Design: Cross-sectional study. Setting: Third National Health Nutrition Examination Survey. Patients: Participants 20 years of age or older were studied in (n = 6217) microalbuminuria 6125) analyses. Measurements: was defined as presence 3 more following factors: elevated blood pressure, low high-density lipoprotein...

10.7326/0003-4819-140-3-200402030-00007 article EN Annals of Internal Medicine 2004-02-03

<h3>Background</h3> The incidence of congestive heart failure (CHF) has been increasing steadily in the United States during past 2 decades. We studied risk factors for CHF and their corresponding attributable First National Health Nutrition Examination Survey Epidemiologic Follow-up Study. <h3>Participants Methods</h3> A total 13 643 men women without a history at baseline examination were included this prospective cohort study. Risk measured using standard methods between 1971 1975....

10.1001/archinte.161.7.996 article EN Archives of Internal Medicine 2001-04-09

With China's rapid economic development, the disease burden may have changed in country. We studied major causes of death and modifiable risk factors a nationally representative cohort 169,871 men women 40 years age older China.Baseline data on participants' demographic characteristics, medical history, lifestyle-related factors, blood pressure, body weight were obtained 1991 with use standard protocol. The follow-up evaluation was conducted 1999 2000, rate 93.4 percent.We documented 20,033...

10.1056/nejmsa050467 article EN New England Journal of Medicine 2005-09-14

IBROBLAST GROWTH FACTOR 23 (FGF-23) is an endocrine hormone that regulates phosphorus metabolism.Circulating levels of FGF-23 increase progressively as kidney function declines, eventually reaching concentrations in patients with chronic disease are among the highest any condition commonly encountered clinical practice. 1Fibroblast growth factor appropriate physiological adaptation to maintain neutral phosphate balance and normal serum setting reduced renal capacity for excretion.Preventing...

10.1001/jama.2011.826 article EN JAMA 2011-06-15

Most studies that have evaluated the association between body-mass index (BMI) and risks of death from any cause specific causes been conducted in populations European origin.We performed pooled analyses to evaluate BMI risk among more than 1.1 million persons recruited 19 cohorts Asia. The included approximately 120,700 deaths occurred during a mean follow-up period 9.2 years. Cox regression models were used adjust for confounding factors.In East Asians, including Chinese, Japanese,...

10.1056/nejmoa1010679 article EN New England Journal of Medicine 2011-02-23

ABSTRACT. Several epidemiologic studies reported that persons with renal insufficiency might have increased cardiovascular disease-related mortality rates in select populations. The association between and all-cause during 16 yr of follow-up monitoring was examined among participants who were 30 to 74 age at the baseline examinations 1976 1980, urinary protein dipstick measurements ( n = 8786) or serum creatinine levels ≤3.0 mg/dl 6354), from Second National Health Nutrition Examination...

10.1681/asn.v133745 article EN Journal of the American Society of Nephrology 2002-03-01

Among patients in the United States with chronic kidney disease, black are at increased risk for end-stage renal as compared white patients.In two studies, we examined effects of variants gene encoding apolipoprotein L1 (APOL1) on progression disease. In African American Study Kidney Disease and Hypertension (AASK), evaluated 693 disease attributed to hypertension. Chronic Renal Insufficiency Cohort (CRIC) study, 2955 (46% whom had diabetes) according whether they 2 copies high-risk APOL1...

10.1056/nejmoa1310345 article EN New England Journal of Medicine 2013-11-09
Coming Soon ...